urokinase medac 500,000 iu, powder for solution for infusion
medac gesellschaft fur klinische spezialpraparate mbh - urokinase - powder for solution for infusion - 500,000 international unit(s) - enzymes; urokinase
bortezomib medac 3.5 mg powder for solution for injection
medac gesellschaft für klinische spezialpräparate mbh - bortezomib - powder for solution for injection - 3.5 milligram(s) - other antineoplastic agents; bortezomib
dacarbazine medac powder for solution for injection or infusion
medac gmbh - dacarbazine (dacarbazine citrate) - powder for solution for injection or infusion - 200mg
melphalan medac 50 mg powder and solvent for solution for injection/infusion
medac gesellschaft für klinische spezialpräparate mbh - melphalan - powder and solvent for solution for injection/infusion - 50 milligram(s) - melphalan
vinorelbine medac 20 mg soft capsules
medac gesellschaft fur klinische spezialpräparate mbh theaterstr. 6 22880 wedel, germany - soft capsule - vinorelbine 20 mg - antineoplastic agents
vinorelbine medac 30 mg soft capsules
medac gesellschaft fur klinische spezialpräparate mbh theaterstr. 6 22880 wedel, germany - soft capsule - vinorelbine 30 mg - antineoplastic agents
vinorelbine medac 80 mg soft capsules
medac gesellschaft fur klinische spezialpräparate mbh theaterstr. 6 22880 wedel, germany - soft capsule - vinorelbine 80 mg - antineoplastic agents
medallion turf fungicide
syngenta australia pty ltd - fludioxonil - suspension concentrate - fludioxonil phenylpyrrole active 125.0 g/l - fungicide
dacarbazine medac 200 mg
tzamal bio-pharma ltd - dacarbazine as citrate - powder for solution for inj/inf - dacarbazine as citrate 200 mg/vial - dacarbazine - dacarbazine - decarbazine is indicated for the treatment of patients with metastatic malignant melanoma. further indications for dacarbazine as part of a combination chemotherapy in advanced hodgkin's disease as a second line.
dacarbazine medac 500 mg
tzamal bio-pharma ltd - dacarbazine as citrate - powder for solution for inj/inf - dacarbazine as citrate 500 mg/vial - dacarbazine - dacarbazine - decarbazine is indicated for the treatment of patients with metastatic malignant melanoma. further indications for dacarbazine as part of a combination chemotherapy in advanced hodgkin's disease as a second line.